Partner Dan Shores will attend the 12th International mRNA Health Conference taking place November 12-14, 2024, in Boston, Massachusetts.
The International mRNA Health Conference is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines. The mRNA Health Conference provides participants an opportunity to learn more about developments in mRNA technologies through scientific presentations by some of the most esteemed experts in the field and extensive networking opportunities. The event brings together over 900 attendees from both academic institutions and leading pharma and biotech companies.
Dan serves companies operating in dynamic biotech and other markets and leads teams in building patent portfolios, negotiating strategic collaborations, conducting due diligence and landscape investigations and litigating complex patent disputes. He has served companies utilizing the following technologies (without limitation): mRNA; lipid nanoparticles; CAR-T therapies; CRISPR; oligonucleotides; genetically engineered swine organs for xenotransplantation; artificial intelligence for drug discovery; pharmaceutical treatment of rhinitis with levocetirizine; pharmaceutical treatment of hepatitis B with telbivudine; and numerous other technologies throughout his 18-year career.
To learn more about the 12th International mRNA Health Conference, and to register, please visit the event website.
